MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Avanos Medical to buy OrthogenRx for $160M

Avanos Medical to buy OrthogenRx for $160M

By

AvanosAvanos Medical today announced it entered into a definitive agreement to acquire OrthogenRx for $160 million.

OrthogenRx makes viscosupplementation therapies to treat knee osteoarthritis pain, as well as commercial hyaluronic acid (HA) therapy products GenVisc 850 and TriVisc. Avanos will purchase the company for $130 million in cash at closing and an additional $30 million in contingent cash consideration upon the achievement of growth milestones related to the HA therapy products.

Get the full story on our sister site, Drug Delivery Business News.

More recent news

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].